MacroMed Inc.
Founded in 1995, MacroMed is a privately-held company developing and manufacturing advanced proprietary biodegradable injectable and oral polymeric drug delivery systems for internal products and products in partnership with pharmaceutical and biotech companies. The Company's platform of technologies is ideal for: enhancing the safety and efficacy of active agents; enabling formulation of insoluble drugs, proteins and peptides or other difficult-to-deliver drugs; and creating new market opportunities or adding value to existing drugs.